- Body Systems
- Health Care
- Threats to Health
- Healthy Living
- medications
- pharmacokinetics
- dosage calculations
- routes of administration
- e-CPS
- Dal Pharm Drug Info
- RxFiles
Section Links
Isoniazid
first-line anti-tuberculosis medication
- uses
- mechanism
- dose and half-life
- side effects
- counter-indications
- metabolism and excretion
- dependency
Uses
- monotherapy is not recommended due to high rates of resistance.
Mechanism
- inhibits formation of the mycobacterial cell wall
Dose and Half Life
Side Effects
short term
long term
Counter-Indications
Metabolism and Excretion
Dependency
This information is for training in careers with many inherent risks. Do not base any decision or action on this site's contents, either for yourself or someone else, without first consulting with a health care professional. Sharing In Health cannot be held responsible for adverse events of any kind.
Please forgive and contact david . lapierre @ dal . ca if you have found any errors of commission or omission as this site develops.